Next Article in Journal
Toxicological Effects of Traumatic Acid and Selected Herbicides on Human Breast Cancer Cells: In Vitro Cytotoxicity Assessment of Analyzed Compounds
Next Article in Special Issue
Chemical Analysis of Lepidium meyenii (Maca) and Its Effects on Redox Status and on Reproductive Biology in Stallions
Previous Article in Journal
Insights into the Regulation of Algal Proteins and Bioactive Peptides Using Proteomic and Transcriptomic Approaches
Previous Article in Special Issue
Chlamyphilone, a Novel Pochonia chlamydosporia Metabolite with Insecticidal Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Issue of Misidentification of Kojic Acid with Flufuran in Aspergillus flavus

by
Marina DellaGreca
1,
Gaetano De Tommaso
1,
Maria Michela Salvatore
1,
Rosario Nicoletti
2,3,
Andrea Becchimanzi
3,
Mauro Iuliano
1 and
Anna Andolfi
1,*
1
Department of Chemical Sciences, University of Naples ‘Federico II’, 80126 Naples, Italy
2
Council for Agricultural Research and Economics, Research Centre for Olive, Citrus and Tree Fruit, 81100 Caserta, Italy
3
Department of Agriculture, University of Naples ‘Federico II’, 80055 Portici, Italy
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(9), 1709; https://doi.org/10.3390/molecules24091709
Submission received: 11 April 2019 / Revised: 24 April 2019 / Accepted: 30 April 2019 / Published: 2 May 2019

Abstract

:
In the course of investigations on the complex phenomenon of bee decline, Aspergillus flavus was isolated from the haemocoel of worker bees. Observations on the metabolomic profile of this strain showed kojic acid to be the dominant product in cultures on Czapek-Dox broth. However, an accurate review of papers documenting secondary metabolite production in A. flavus also showed that an isomer of kojic acid, identified as 5-(hydroxymethyl)-furan-3-carboxylic acid and named flufuran is reported from this species. The spectroscopic data of kojic acid were almost identical to those reported in the literature for flufuran. This motivated a comparative study of commercial kojic acid and 5-(hydroxymethyl)-furan-3-carboxylic acid, highlighting some differences, for example in the 13C-NMR and UV spectra for the two compounds, indicating that misidentification of the kojic acid as 5-(hydroxymethyl)-furan-3-carboxylic acid has occurred in the past.

Graphical Abstract

1. Introduction

Fungi have evolved the capability to produce a great number of secondary metabolites involved in the improvement of their ecological fitness, and many of them play important biological roles as virulence factors, chemical defense agents, developmental regulators, insect attractants, and chemical signals for communication with other organisms. On these properties is founded the pharmacological exploitation of many products as antibiotic, antiviral, antitumor, antihypercholesterolemic, and immunosuppressant agents [1,2,3,4,5]. In this respect, fungi are prime targets of a vigorous investigational activity, based on the employment of the most advanced analytical and structure elucidation techniques [6,7].
A wide array of fungal secondary metabolites has been ascribed to the ascomycete genus Aspergillus, well-known for its ubiquity and cosmopolitan distribution [7,8]. The species Aspergillus flavus is well-known as a foodstuff contaminant and a mycotoxin producer, and in this respect its metabolomic profile has been quite well characterized [9,10]. However, this fungus has been also reported in association with plants and animals in many different environments [11,12]. Particularly, it has been directly isolated from bee (Apis mellifera) individuals in different developmental stages and health conditions [13]. Although reported as the agent of stonebrood disease, further elucidation is required if A. flavus basically behaves like an entomopathogen, or if its relationships with bees are more complex and eventually involve modulation of the immunitary response to other pathogens and parasites of these insects. Generally, the fungus is considered an opportunistic pathogen of immunocompromised individuals, gaining access to the host through ingestion, or taking advantage from the interaction of bees with other pathogens and parasites which negatively affect host immunocompetence and cuticle integrity [13,14,15,16].
During investigations on the honeybee colony collapse, a multifactorial syndrome mainly related to the compresence of immunosuppressive viruses and Varroa destructor, a parasitic mite which is also known as a possible vector [16,17,18], strains of A. flavus were repeatedly isolated from the haemocoel of worker bees.
The present paper reports the identification of kojic acid (KA) as the main metabolite obtained from this source. Furthermore, revision of the structure of flufuran, previously characterized as 5-(hydroxymethyl)furan-3-carboxylic acid from A. flavus and other fungal species is proposed, based on a comparison of spectroscopic data of commercially available compounds and some derivatives.

2. Results

2.1. Comparison of NMR Data Obtained from KA (1) and 5-(Hydroxymethyl)furan-3-carboxylic Acid (2)

A white solid was obtained from the extraction with ethyl acetate (EtOAc) of the culture filtrate of strain AB1EET of A. flavus, which consisted in a main metabolite, as deduced by its 1H and 13C-NMR spectra. NMR data collected for the extracted compound showed significant similarities with proton and carbon chemical shifts reported in literature for both KA (1) [19] and 5-(hydroxymethyl)furan-3-carboxylic acid (2) [20], a compound characterized from A. flavus and other fungal species (Table 1). A full analysis of the previous reports revealed discrepancy between the carbon chemical shifts of furan compounds [21] and those assigned for 5-(hydroxymethyl)furan-3-carboxylic acid. In order to clarify this issue, commercially available KA and 5-(hydroxymethyl)furan-3-carboxylic acid were submitted to spectroscopic and potentiometric investigations.
The comparison of 1H-NMR spectra, recorded in CD3OD, showed no significant differences between 5-(hydroxymethyl)furan-3-carboxylic acid and KA (Figure 1 and Figure 2). Notwithstanding, the 1H-NMR spectra recorded in DMSOd6 for 2 revealed the coupling between the proton of the hydroxyl group in C-7 and protons of the methylene group which resonate as triplet and doublet, respectively, at δ 5.31 and 4.40 (J = 5.8 Hz) and the presence of the signal of proton of the carboxylic group at δ 12.60 (Figure 3).
The main differences between 1 and 2 were observed, as expected, in 13C-NMR spectra. The C-3, C-5 and C-6 carbons of 2 resonate at δ 120.1, 156.4 e 165.1 (Figure 2 and Figure S1), respectively, assigned by 2D-NMR spectra (Figures S2 and S3). However, the 13C-NMR spectrum of flufuran showed chemical shift values identical to KA (Figure 2), indicating a misinterpretation of the flufuran structure.

2.2. Comparison of Potentiometric, UV, and MS Spectrophotometric Measurements

The acid-base behavior of KA and 5-(hydroxymethyl)furan-3-carboxylic acid was determined by potentiometric and spectrophotometric methods. The calculated protonation constants cologarithm values are 7.68 ± 0.05 and 4.03 ± 0.05, for compound 1 and 2 respectively. Potentiometric data are reported in Figure 4.
In particular KA constant is very similar to that in 0.1 M KCl (7.7) [33]. While no value on the protonation of 5-(hydroxymethyl)furan-3-carboxylic acid had been previously reported.
UV spectra of the pure compounds, recorded in water in the interval 200–400 nm, show λmax at 216 and 270 nm for KA, and at 240 nm for 2. Similar values were observed when the spectra were recorded in methanol.
In agreement with acid-base behavior of both compounds, measurements conducted in pH function confirmed that KA spectra are highly influenced by pH [34]. In fact, absorbance value at 315 nm increases from 3 to 9 pH range, instead the peak at 270 nm decreases in the same interval. Conversely, UV spectra of compound 2 present minimal variation in function of pH (Figure 5). Finally with pH increasing, KA shows a isosbestic point at 285 nm, while 5-(hydroxymethyl)furan-3-carboxylic acid presents one at 240 nm.
The fragmentation pattern observed in MALDI TOF/MS spectra evidenced relevant analogies between the two compounds, as to be expected from considering the nature of the respective functional groups. In fact, from peaks corresponding to the protonated ions [M+H]+ at m/z 143 of 1 and 2, fragments deriving from the loss of OH, CHO, and COOH groups were observed in both cases.

2.3. Comparison of KA and 5-(Hydroxymethyl)furan-3-carboxylic Acid Derivatives

Considering reports concerning the presumptive isolation of the 7-O-acetyl derivative of flufuran [25] and of its methyl ester [29], in this work the differences between derivatives of 1 and 2 obtained from common acetylation and methylation reaction were also evaluated.
The proton spectrum of 5-(acetoxymethyl)furan 3-carboxylic acid (4, Figure S4), produced after acetylation of 2, showed the down shift of Δδ 0.55 of the signal assigned to the methylene group C-7 which resonates as singlet at δ 5.08, and the presence of a further singlet at δ 2.07 assigned to the CH3 of the acetyl group (Figure 6 and Figure S4). As discussed in relation to 1 and 2 the differences between the 1H-NMR spectra of 4 and 7-O-acetylflufuran [25] are not so marked compared to the ones of 13C-NMR spectra (Figure 6 and Figure S5).
From the data reported on the diacetylated flufuran [22], it is possible to exclude its formation from 2; most likely the described compound is 5,7-O,O′-diacetylKA (5, Figure 6), derived from 1.
The treatment of 1 and 2 with diazomethane led to the production of 5-O-methylKA (6) and methyl 5-(hydroxymethyl)furan-3-carboxylate (7, Figure 6) as deduced from 1H and 13C-NMR spectra. In fact, NMR spectra of 7 (Figures S6 and S7) showed further singlets, respectively, at δ 3.83 and at δ 50.6 attributed to methoxy group. As observed for the other compounds under examination, the comparison of 13C-NMR spectra of methyl derivatives of 1 and 2 revealed significant differences (6 and 7, Figure 6).
Finally, the preparation of 5-O-methyl-7-O’-acetylKA (8) and methyl 5-(acetoxymethyl)furan-3-carboxylate (9) and the interpretation of their one-dimensional NMR spectra (Figures S8 and S9) allowed to confirm the derivative structures, and to establish that the derivative i.e., methyl 5-(acetoxymethyl)furan-3-carboxylate) reported by Evidente et al. [22] is undoubtedly 8.

3. Discussion

The furan compound 5-(hydroxymethyl)furan-3-carboxylic acid was identified for the first time as a natural product in cultures of Polyporus ciliatus [20], and afterwards reported from other fungi (Table 1). Although furan derivatives are not an extensive class of fungal compounds [35], over the past few years the literature concerning these natural products has been enriched by new reports [36,37,38,39,40]. According to their biosynthetic origin, the structure of natural furan derivatives shows the presence of furan rings substituted in position 2 and 5 [35]. Flufuran represented an exception to such a general model.
In the present paper, we produce evidence that in most of the previous reports the product identified as flufuran was instead KA. In addition to being known as a typical secondary metabolite of both A. flavus and A. oryzae, KA has been reported from several Penicillium spp. [41]. Other fungal species are claimed as producers of some derivatives [42], indicating that biosynthetic ability for this compound might be more widespread. To the best of our knowledge, our amendments to previous findings represents the first evidence of its production in important fungal genera, such as Fusarium and Pestalotiopsis, which deserve further confirmation also with reference to correct taxonomic identification of producing strains. In view of the present revision, the bioactivities erroneously assigned to flufuran should be instead referred to KA, integrating the known profile of biological properties of this γ-pyrone compound [43]. Actually, these data show that KA and 5-(hydroxymethyl)furan-3-carboxylic acid are susceptible of misidentification. Particularly, some instrumental techniques commonly used for the identification of secondary metabolites in fungal extracts (i.e., 1H-NMR and ESI MS data) are not able to distinguish between these two compounds. However, huge differences can be observed between 1 and 2 in the UV spectra obtained with different solvents and pH. The acid-base properties are also valid to differentiate between 1 and 2. Finally, observations concerning acetyl and methyl derivatives also confirmed the misidentification of KA with flufuran.

4. Materials and Methods

4.1. General Experimental Procedures

1H and 13C-NMR spectra were recorded at 400 and at 100 MHz, respectively, in CD3OD unless otherwise noted, on a Bruker spectrometer (AscendTM400) (Bremen, Germany); the same solvent was used as internal standard. Potentiometric titrations were performed in an air-bath thermostat kept at (25.00 ± 0.05) °C. A programmable computer-controlled Data Acquisition Unit 34970A, (Agilent Tecnologies Inc., Santa Clara, CA, USA) was used to perform the potentiometric measurements. The glass electrodes were Metrohm (Herisau, Switzerland) of 60102-100 type, and Ag/AgCl electrode was utilized as reference. The EMF values were measured with a precision of ± 0.01 mV using a Keithley 642 type Digital Electrometer (Tektronix Inc., Beaveron, OR, USA). UV–VIS spectra were recorded by model Cary 5000 Spectrophotometer by Varian (Palo Alto, CA, USA) from 200 to 600 nm (optical path 0.2 cm) at 25.0 °C, under a constant flow of nitrogen.
MALDI-TOF/MS spectra were acquired by a 4700 Proteomics Analyzer (Applied Biosystems, Framingham, MA, USA). Compounds were detected in reflector mode using α-cyano-4-hydroxycinnamic acid (CHCA) as matrix.
Analytical and preparative TLC were performed on silica gel plates (Kieselgel 60, F254, 0.25 mm) (Merck, Darmstadt, Germany). The spots were visualized by exposure to UV radiation (253 nm), or by spraying with 10% H2SO4 in MeOH followed by heating at 110 °C for 10 min. 5-(hydroxymethyl)furan-3-carboxylic acid and KA were purchased from Enamine Ltd. (Kyiv, Ukraine) and Alfa Aesar (Karlsruhe, Germany), respectively.

4.2. Isolation of A. flavus from Bees

Worker bee individuals were collected from experimental apiaries at the Department of Agriculture, University of Naples Federico II (Portici, Italy) in October–November 2018. Freshly emerged bees (<48 h) were anaesthetized by chilling on ice for 20 min, and surface-disinfected by dipping in 70% ethanol for 30 s. The intersegmental membrane between head and thorax was cut using a sterile scalpel. Ten microliters of the liquid matter exuding from haemocoel were aseptically collected using a micropipette, and spotted on potato-dextrose agar (PDA, Oxoid) amended with 50 mg/L chloramphenicol. Plates were incubated at 32 °C in the dark. Hyphal tips from the emerging fungal colonies were transferred to fresh PDA plates to obtain pure cultures for morphological identification and storage. The strains obtained were readily identified as belonging to the Aspergillus section Flavi, based on the formation of colonies producing a dense felt of yellow-green rough conidiophores with radiate heads, and subglobose echinulate conidia. An orange reverse could be observed in cultures on a specific medium (AFPA) [44]. Unequivocal ascription to the species A. flavus resulted after rDNA-ITS and calmodulin gene sequencing. To this purpose, total genomic DNA was extracted from fresh mycelium taken from pure culture of strain AB1EET using CTAB protocol [45]. According to reported methodology, primers ITS1F and ITS4 were used to amplify rDNA-ITS, while primers CF1M and CF4 were used to amplify the calmodulin gene [45,46]. The original DNA sequences obtained in this study have been deposited in GenBank under the codes MK611561 (ITS) and MK611938 (calmodulin). The calmodulin gene sequence proved to be more respondent for unequivocal species identification, yielding 100% homology with sequences from 60 strains of A. flavus available in GenBank.

4.3. Production and Extraction of KA

Strain AB1EET was cultured in Czapek-Dox broth (Oxoid) following a previously reported procedure [47]. The freeze-dried culture filtrates (750 mL) were dissolved in 100 mL, acidified with HCl 2 N at pH 3, and extracted three times with an equal volume of EtOAc. Organic phases were combined, dried with Na2SO4, and evaporated under reduced pressure originating a white solid residue (350.7 mg) identified as KA.

4.4. Determination of Protonation Constants

The evaluation of the protolysis constants was conducted through spectrophotometric and potentiometric titration, at 25 °C in 0.1 M NaClO4 as ionic medium [48]. By experimental data the average number (ZH) of protons released per molecule was assessed through the equation:
ZH = ([H+] − CH − Kw/[H+])/CL
where [H+] is hydrogenionic concentration, CH is the total acid concentration, CL is the compound concentration and Kw is ionic product (10−13.7, in 0.1 M NaClO4). Experimental data were processed with Hyperquad softare [49].

4.5. UV and MS Data of KA and 5-(Hydroxymethyl)furan-3-carboxylic Acid

Kojic acid (1). UV λmax nm (log ε): (H2O) 216 (4.12), 270 (3.93); (MeOH) 225 (3.99), 270 (3.99); (pH 3.0) 215 (3.47), 270 (3.30); (pH 5.0) 216 (3.51), 268 (3.17), 318 (2.63); (pH 8.0) 227 (3.66), 315 (3.5); (pH 9.0) 227 (3.72), 315 (3.15). MALDI TOF/MS: m/z 143 [M+H]+, 125 [M-OH]+, 113 [M-CHO]+, 97 [M-COOH]+, 69 [M-CH2OH-COO]+.
5-(Hydroxymethyl)furan-3-carboxylic acid (2). UV λmax nm (log ε): (H2O) 240 (3.39); (MeOH) 240 (3.38); (pH 2.5) 243 (2.97); (pH 3.0) 243 (3.07); (pH 4.0) 243 (3.07); (pH 5.0) 243 (3.12). MALDI TOF/MS: m/z 143 [M+H]+, 125 [M-OH]+, 113 [M-CHO]+, 97 [M-COOH]+.

4.6. Sample Methylation

Fifteen milligrams of samples [KA, 5-(hydroxymethyl)furan-3-carboxylic acid, 5-(acetoxymethyl)furan-3-carboxylic acid (1, 2 and 4)] were dissolved in MeOH (1.5 mL); an ethereal solution of CH2N2 was slowly added until a yellow color became persistent. The reaction mixtures were stirred at room temperature for 4 h. The solvent was evaporated under a N2 stream at room temperature. Residues of each reaction were analyzed by TLC on silica gel; 6, was evidenced at Rf 0.37 by eluting with EtOAc-MeOH (9:1), while Rf 0.54 and 0.82 corresponded to 7 and 9 respectively, as eluted with CHCl3-i-PrOH (92:8).

4.7. Sample Acetylation

Ten mg of samples [KA, 5-(hydroxymethyl)furan-3-carboxylic acid, 5-O-methylkojic acid (1, 2, 6)], dissolved in pyridine (30 μL), were converted into the corresponding acetyl derivatives (5, 4, 7) by acetylation with Ac2O (30 μL) at room temperature overnight. The reaction was stopped by addition of MeOH, and the azeotrope formed by addition of benzene was evaporated in a N2 stream at 40 °C. Residues of each reaction were analyzed by TLC on silica gel; 5 was evidenced at Rf 0.44 by eluting with CHCl3-i-PrOH (95:5), while Rf 0.54 and 0.82 corresponded to 7 and 9 respectively, as eluted with CHCl3-i-PrOH (92:8).

Supplementary Materials

The following are available online, Figures S1–S3. NMR spectra of KA (1) and 5-(hydroxymethyl)furan-3-carboxylic acid (2); Figures S4–S9. 1H and 13C-NMR spectra of acetyl and methyl derivatives of 2.

Author Contributions

M.D., R.N., and A.A. conceived and organized the manuscript, and wrote the text; R.N. and A.B. isolated and cultivated the fungal strain; M.M.S. and A.A. extracted the culture filtrate and prepared sample derivatives; M.D. and A.A. performed the NMR analysis; G.D.T. and M.I. performed potentiometric and spectrophotometric measurements; M.D., M.M.S, R.N., and A.A edited and reviewed the manuscript.

Funding

This research was funded by Finanziamento delle Attività Base della Ricerca (FFABR) 2017 of Ministero dell’Istruzione, dell’Università e della Ricerca (MIUR, Italy).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chambergo, F.S.; Valencia, E.Y. Fungal biodiversity to biotechnology. Appl. Microbiol. Biotechnol. 2016, 100, 2567–2577. [Google Scholar] [CrossRef] [PubMed]
  2. Meyer, V.; Andersen, M.R.; Brakhage, A.A.; Braus, G.H.; Caddick, M.X.; Cairns, T.C.; de Vries, R.P.; Haarmann, T.; Hansen, K.; Hertz-Fowler, C.; et al. Current challenges of research on filamentous fungi in relation to human welfare and a sustainable bio-economy: A white paper. Fungal Biol. Biotechnol. 2016, 3, 6. [Google Scholar]
  3. Nicoletti, R.; Salvatore, M.M.; Andolfi, A. Secondary metabolites of mangrove-associated strains of Talaromyces. Mar. Drugs 2018, 16, 12. [Google Scholar] [CrossRef] [PubMed]
  4. Félix, C.; Salvatore, M.M.; DellaGreca, M.; Meneses, R.; Duarte, A.S.; Salvatore, F.; Naviglio, D.; Gallo, M.; Jorrino-Novo, J.V.; Alves, A.; et al. Production of toxic metabolites by two strains of Lasiodiplodia theobromae, isolated from a coconut tree and a human patient. Mycologia 2018, 110, 642–653. [Google Scholar] [CrossRef] [PubMed]
  5. Marra, R.; Nicoletti, R.; Pagano, E.; DellaGreca, M.; Salvatore, M.M.; Borrelli, F.; Lombardi, N.; Vinale, F.; Woo, S.L.; Andolfi, A. Inhibitory effect of trichodermanone C, a sorbicillinoid produced by Trichoderma citrinoviride associated to the green alga Cladophora sp., on nitrite production in LPS-stimulated macrophages. Nat. Prod. Res. 2018. [Google Scholar] [CrossRef]
  6. Keller, N.P.; Turner, G.; Bennett, J.W. Fungal secondary metabolism—from biochemistry to genomics. Nat. Rev. Microbiol. 2005, 3, 937. [Google Scholar] [CrossRef] [PubMed]
  7. Salvatore, M.M.; Nicoletti, R.; Salvatore, F.; Naviglio, D.; Andolfi, A. GC–MS approaches for the screening of metabolites produced by marine-derived Aspergillus. Mar. Chem. 2018, 206, 19–33. [Google Scholar] [CrossRef]
  8. Samson, R.A.; Visagie, C.M.; Houbraken, J.; Hong, S.B.; Hubka, V.; Klaassen, C.H.W.; Perrone, G.; Seifert, K.A.; Susca, A.; Tanney, J.B.; et al. Taxonomy, identification and nomenclature of the genus Aspergillus. Stud. Mycol. 2014, 78, 141–173. [Google Scholar] [CrossRef]
  9. Rank, C.; Klejnstrup, M.L.; Petersen, L.M.; Kildgaard, S.; Frisvad, J.C.; Held Gotfredsen, C.; Ostenfeld Larsen, T. Comparative chemistry of Aspergillus oryzae (RIB40) and A. flavus (NRRL 3357). Metabolites 2012, 2, 39–56. [Google Scholar] [CrossRef]
  10. Cary, J.W.; Gilbert, M.K.; Lebar, M.D.; Majumdar, R.; Calvo, A.M. Aspergillus flavus secondary metabolites: More than just aflatoxins. Food Safety 2018, 6, 7–32. [Google Scholar] [CrossRef]
  11. Nicoletti, R.; Fiorentino, A. Plant bioactive metabolites and drugs produced by endophytic fungi of Spermatophyta. Agriculture 2015, 5, 918–970. [Google Scholar] [CrossRef]
  12. Ramírez-Camejo, L.A.; Zuluaga-Montero, A.; Lázaro-Escudero, M.; Hernández-Kendall, V.; Bayman, P. Phylogeography of the cosmopolitan fungus Aspergillus flavus: Is everything everywhere? Fungal Biol. 2012, 116, 452–463. [Google Scholar] [CrossRef] [PubMed]
  13. Foley, K.; Fazio, G.; Jensen, A.B.; Hughes, W.O. The distribution of Aspergillus spp. opportunistic parasites in hives and their pathogenicity to honey bees. Veter. Microbiol. 2014, 169, 203–210. [Google Scholar] [CrossRef] [PubMed]
  14. Vojvodic, S.; Jensen, A.B.; James, R.R.; Boomsma, J.J.; Eilenberg, J. Temperature dependent virulence of obligate and facultative fungal pathogens of honeybee brood. Veter. Microbiol. 2011, 149, 200–205. [Google Scholar] [CrossRef]
  15. Ilyasov, R.; Gaifullina, L.; Saltykova, E.; Poskryakov, A.; Nikolenko, A. Review of the expression of antimicrobial peptide defensin in honey bees Apis mellifera L. J. Apicultural Sci. 2012, 56, 115–124. [Google Scholar] [CrossRef]
  16. Di Prisco, G.; Annoscia, D.; Margiotta, M.; Ferrara, R.; Varricchio, P.; Zanni, V.; Caprio, E.; Nazzi, F.; Pennacchio, F. A mutualistic symbiosis between a parasitic mite and a pathogenic virus undermines honey bee immunity and health. Proc. Natl. Acad. Sci. 2016, 113, 3203–3208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Benoit, J.B.; Yoder, J.A.; Sammataro, D.; Zettler, L.W. Mycoflora and fungal vector capacity of the parasitic mite Varroa destructor (Mesostigmata: Varroidae) in honey bee (Hymenoptera: Apidae) colonies. Int. J. Acarology 2004, 30, 103–106. [Google Scholar] [CrossRef]
  18. Yang, X.; Cox-Foster, D.L. Impact of an ectoparasite on the immunity and pathology of an invertebrate: Evidence for host immunosuppression and viral amplification. Proc. Natl. Acad. Sci. 2005, 102, 7470–7475. [Google Scholar] [CrossRef] [Green Version]
  19. Li, X.; Jeong, J.H.; Lee, K.T.; Rho, J.R.; Choi, H.D.; Kang, J.S.; Son, B.W. γ-Pyrone derivatives, kojic acid methyl ethers from a marine-derived fungus Altenaria sp. Arch. Pharm. Res. 2003, 26, 532–534. [Google Scholar] [CrossRef]
  20. Cabrera, G.M.; Roberti, M.J.; Wright, J.E.; Seldes, A.M. Cryptoporic and isocryptoporic acids from the fungal cultures of Polyporus arcularius and P. ciliatus. Phytochemistry 2002, 61, 189–193. [Google Scholar] [CrossRef]
  21. Alvarez-Ibarra, C.; Quiroga-Feijóo, M.L.; Toledano, E. An analysis of substituent effects on 1H and 13C-NMR parameters of substituted furans. Linear free energy relationships and PM3 semiempirical calculations. J. Chem. Soc., Perkin Trans. 2 1998, 3, 679–690. [Google Scholar] [CrossRef]
  22. Evidente, A.; Cristinzio, G.; Punzo, B.; Andolfi, A.; Testa, A.; Melck, D. Flufuran, an antifungal 3,5-disubstituted furan produced by Aspergillus flavus Link. Chem. Biodiver. 2009, 6, 328–334. [Google Scholar] [CrossRef] [PubMed]
  23. Balde, E.S.; Andolfi, A.; Bruyère, C.; Cimmino, A.; Lamoral-Theys, D.; Vurro, M.; Damme, M.V.; Altomare, C.; Mathieu, V.; Kiss, R.; et al. Investigations of fungal secondary metabolites with potential anticancer activity. J. Nat. Prod. 2010, 73, 969–971. [Google Scholar] [CrossRef] [PubMed]
  24. Ma, C.; Ma, Y.M.; Li, T.; Wang, J. Structure and activity of secondary metabolites of endophytic fungus S19 strain in Cephalotaxus fortune. Guizhou Nongye Kexue 2014, 42, 152–156. [Google Scholar]
  25. Ma, Y.M.; Ma, C.C.; Li, T.; Wang, J. A new furan derivative from an endophytic Aspergillus flavus of Cephalotaxus fortunei. Nat. Prod. Res. 2016, 30, 79–84. [Google Scholar] [CrossRef] [PubMed]
  26. Saldan, N.C.; Almeida, R.T.; Avíncola, A.; Porto, C.; Galuch, M.B.; Magon, T.F.; Pilau, E.J.; Svidzinski, T.I.E.; Oliveira, C.C. Development of an analytical method for identification of Aspergillus flavus based on chemical markers using HPLC-MS. Food Chem. 2018, 241, 113–121. [Google Scholar] [CrossRef]
  27. Lee, M.; Cho, J.Y.; Lee, Y.G.; Lee, H.J.; Lim, S.I.; Lee, S.Y.; Nam, Y.D.; Moon, J.H. Furan, phenolic, and heptelidic acid derivatives produced by Aspergillus oryzae. Food Sci. Biotechnol. 2016, 25, 1259–1264. [Google Scholar] [CrossRef]
  28. Yang, X.; Wang, P.; Ma, Y.; Jia, Q. Metabolites of Aspergillus oryzae, an endophytic fungus associated with Lycium ruthenicum Murr. Tianran Chanwu Yanjiu Yu Kaifa 2015, 27, 1554–1557. [Google Scholar]
  29. Zhang, H.C.; Ma, Y.M.; Liu, R. Antimicrobial materials derived from the endophytic fungus Fusarium sp. of Eucommia ulmoides. Advan. Mater. Res. 2012, 531, 346–349. [Google Scholar] [CrossRef]
  30. He, S.; Yan, X.; Wang, T. Marine Penicillium dipodomyicola for manufacture of flufuran. 2014, CN 104031845 A 20140910. CN 104031845 A 20140910, 2014. [Google Scholar]
  31. Elsunni, M.A.; Yang, Z.-D. Secondary metabolites of the endophytic fungi Penicillium polonicum and their monoamine oxidase inhibitory activity. Chem. Nat. Comp. 2018, 54, 1018–1019. [Google Scholar] [CrossRef]
  32. Zhou, J.; Li, G.; Deng, Q.; Zheng, D.; Yang, X.; Xu, J. Cytotoxic constituents from the mangrove endophytic Pestalotiopsis sp. induce G0/G1 cell cycle arrest and apoptosis in human cancer cells. Nat. Prod. Res. 2018, 32, 2968–2972. [Google Scholar] [CrossRef]
  33. Nurchi, V.M.; Crisponi, G.; Lachowicz, J.I.; Murgia, S.; Pivetta, T.; Remelli, M.; Rescigno, A.; Niclós-Gutìerrez, J.; González-Pérez, J.M.; Domìnguez-Martìn, A.; et al. Iron (III) and aluminum (III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives. J. Inorg. Biochem. 2010, 104, 560–569. [Google Scholar] [CrossRef] [PubMed]
  34. Paterson, R.R.M.; Kemmelmeier, C. Neutral, alkaline and difference ultraviolet spectra of secondary metabolites from Penicillium and other fungi, and comparisons to published maxima from gradient high-performance liquid chromatography with diode-array detection. J. Chromatogr. A 1990, 511, 195–221. [Google Scholar] [CrossRef]
  35. Klaiklay, S.; Rukachaisirikul, V.; Phongpaichit, S.; Buatong, J.; Preedanon, S.; Sakayaroj, J. Flavodonfuran: A new difuranylmethane derivative from the mangrove endophytic fungus Flavodon flavus PSU-MA201. Nat. Prod. Res. 2013, 27, 1722–1726. [Google Scholar] [CrossRef] [PubMed]
  36. Kobori, H.; Sekiya, A.; Yasuda, N.; Noguchi, K.; Suzuki, T.; Choi, J.H.; Hirai, H.; Kawagishi, H. Armillariols A to C from the culture broth of Armillaria sp. Tetrahedron Lett. 2013, 54, 5481–5483. [Google Scholar] [CrossRef]
  37. Ding, L.J.; Gu, B.B.; Jiao, W.H.; Yuan, W.; Li, Y.X.; Tang, W.Z.; Yu, H.B.; Liao, X.J.; Han, B.N.; Li, Z.Y.; et al. New furan and cyclopentenone derivatives from the sponge-associated fungus Hypocrea koningii PF04. Mar. Drugs 2015, 13, 5579–5592. [Google Scholar] [CrossRef]
  38. Chen, L.L.; Wang, P.; Chen, H.Q.; Guo, Z.K.; Wang, H.; Dai, H.F.; Mei, W.L. New furan derivatives from a mangrove-derived endophytic fungus Coriolopsis sp. J5. Molecules 2017, 22, 261. [Google Scholar] [CrossRef] [PubMed]
  39. Uchoa, P.K.S.; Pimenta, A.T.; Braz-Filho, R.; de Oliveira, M.D.C.F.; Saraiva, N.N.; Rodrigues, B.S.; Pfenning, L.H.; Abreu, L.M.; Wilke, D.V.; Florêncio, K.G.D.; et al. New cytotoxic furan from the marine sediment-derived fungi Aspergillus niger. Nat. Prod. Res. 2017, 31, 2599–2603. [Google Scholar] [CrossRef] [PubMed]
  40. Wu, X.; Pang, X.J.; Xu, L.L.; Zhao, T.; Long, X.Y.; Zhang, Q.Y.; Qin, H.L.; Yang, D.F.; Yang, X.L. Two new alkylated furan derivatives with antifungal and antibacterial activities from the plant endophytic fungus Emericella sp. XL029. Nat. Prod. Res. 2018, 32, 2625–2631. [Google Scholar] [CrossRef] [PubMed]
  41. Bentley, R. From miso, sake and shoyu to cosmetics: A century of science for kojic acid. Nat. Prod. Rep. 2006, 23, 1046–1062. [Google Scholar] [CrossRef] [PubMed]
  42. Dembitsky, V.M.; Kilimnik, A. Anti-melanoma agents derived from fungal species. Mathews, J. Pharm. Sci. 2016, 1, 002. [Google Scholar]
  43. Mohamad, R.; Mohamed, M.S.; Suhaili, N.; Salleh, M.M.; Ariff, A.B. Kojic acid: Applications and development of fermentation process for production. Biotechnol. Mol. Biol. Rev. 2010, 5, 24–37. [Google Scholar]
  44. Pitt, J.I.; Hocking, A.D.; Glenn, D.R. An improved medium for the detection of Aspergillus flavus and A. parasiticus. J. Appl. Bacteriol. 1983, 54, 109–114. [Google Scholar] [CrossRef] [PubMed]
  45. Cubero, O.F.; Crespo, A.; Fatehi, J.; Bridge, P.D. DNA extraction and PCR amplification method suitable for fresh, herbarium-stored, lichenized, and other fungi. Plant Syst. Evol. 1999, 216, 243–249. [Google Scholar] [CrossRef]
  46. Peterson, S.W. Phylogenetic analysis of Aspergillus species using DNA sequences from four loci. Mycologia 2008, 100, 205–226. [Google Scholar] [CrossRef] [PubMed]
  47. Nicoletti, R.; Buommino, E.; De Filippis, A.; Lopez-Gresa, M.P.; Manzo, E.; Carella, A.; Petrazzuolo, M.; Tufano, M.A. Bioprospecting for antagonistic Penicillium strains as a resource of new antitumor compounds. World J. Microbiol. Biotechnol. 2008, 24, 189–195. [Google Scholar] [CrossRef]
  48. Meloun, M.; Havel, J.; Högfeldt, E. Computation of Solution Equilibria: A Guide to Methods in Potentiometry, Extraction and Spectrophotometry; Ellis Horwood Ltd.: Chichester, UK, 1988. [Google Scholar]
  49. Gans, P.; Sabatini, A.; Vacca, A. Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. Talanta 1996, 43, 1739–1753. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds 1-9 are available from the authors.
Figure 1. 1H-NMR spectra of KA (1, red) and 5-(hydroxymetyhyl)-furan 3-carboxylic acid (2, green) recorded at 400 MHz in CD3OD.
Figure 1. 1H-NMR spectra of KA (1, red) and 5-(hydroxymetyhyl)-furan 3-carboxylic acid (2, green) recorded at 400 MHz in CD3OD.
Molecules 24 01709 g001
Figure 2. Proton and carbon chemical shifts of KA (1) and 5-(hydroxymethyl)furan-3-carboxylic acid (2). Data reported in red were erroneously assigned to flufuran. The spectra were recorded in CD3OD.
Figure 2. Proton and carbon chemical shifts of KA (1) and 5-(hydroxymethyl)furan-3-carboxylic acid (2). Data reported in red were erroneously assigned to flufuran. The spectra were recorded in CD3OD.
Molecules 24 01709 g002
Figure 3. 1H-NMR spectra of KA (1, red) and 5-(hydroxymetyhyl)-furan 3-carboxylic acid (2, green) recorded at 400 MHz in DMSOd6.
Figure 3. 1H-NMR spectra of KA (1, red) and 5-(hydroxymetyhyl)-furan 3-carboxylic acid (2, green) recorded at 400 MHz in DMSOd6.
Molecules 24 01709 g003
Figure 4. ZH(pH) function in 0.1 M NaClO4 for KA (squares) and 5-(hydroxymethyl)furan-3-carboxylic acid (circles). The solid lines are calculated with protonation constants cologarithm value 7.68 (on squared) and 4.03 (on circles).
Figure 4. ZH(pH) function in 0.1 M NaClO4 for KA (squares) and 5-(hydroxymethyl)furan-3-carboxylic acid (circles). The solid lines are calculated with protonation constants cologarithm value 7.68 (on squared) and 4.03 (on circles).
Molecules 24 01709 g004
Figure 5. (A) UV spectra of 2.0 × 10−3 M in 0.1 M NaClO4 for KA. (B) UV spectra of 2.0 × 10−3 M in 0.1 M NaClO4 for 5-(hydroxymethyl)furan-3-carboxylic acid (optical path 0.2 cm).
Figure 5. (A) UV spectra of 2.0 × 10−3 M in 0.1 M NaClO4 for KA. (B) UV spectra of 2.0 × 10−3 M in 0.1 M NaClO4 for 5-(hydroxymethyl)furan-3-carboxylic acid (optical path 0.2 cm).
Molecules 24 01709 g005
Figure 6. Proton and carbon chemical shifts of 7-O-acetylKA, 5,7-O,O’-diacetylKA, 5-O-methylKA, 5-O-methyl-7-O’-acetylKA (3, 5, 6, and 8); 5-(acetoxymethyl)furan-3-carboxylic acid, methyl 5-(hydroxymethyl)furan-3-carboxylate, methyl 5-(acetoxymethyl)furan-3-carboxylate (4, 7, and 9).
Figure 6. Proton and carbon chemical shifts of 7-O-acetylKA, 5,7-O,O’-diacetylKA, 5-O-methylKA, 5-O-methyl-7-O’-acetylKA (3, 5, 6, and 8); 5-(acetoxymethyl)furan-3-carboxylic acid, methyl 5-(hydroxymethyl)furan-3-carboxylate, methyl 5-(acetoxymethyl)furan-3-carboxylate (4, 7, and 9).
Molecules 24 01709 g006
Table 1. Previous reports dealing with flufuran identification.
Table 1. Previous reports dealing with flufuran identification.
SourceSpectroscopic DataActivityRef.
Aspergillus flavus1H and 13C-NMR, MS, IR, UVAntifungal[22]
A. flavusCytotoxic against human cancer cell lines[23]
A. flavus Bacteriostatic (Escherichia coli)[24] 1
A. flavus21H and 13C-NMRAntibacterial, antioxidant[25]
A. flavusMS[26]
Aspergillus oryzae[27]
A. oryzae1Antioxidant, antimicrobial[28]
Fusarium sp.31H and 13C-NMRAntimicrobial[29]
Penicillium dipodomyicola1H and 13C-NMR[30]
Penicillium polonicumMonoamine oxidase inhibitor[31]
Pestalotiopsis sp.1H and 13C-NMRCytotoxic against HepG2 cells[32]
Polyporus ciliatusP.f., MS, 1H and 13C-NMR, MS, IR, UV[20]
1 This paper is in Chinese and could not be examined in detail. 2 7-O-Acetyl derivative was also isolated. 3 Methyl ester was also isolated.

Share and Cite

MDPI and ACS Style

DellaGreca, M.; De Tommaso, G.; Salvatore, M.M.; Nicoletti, R.; Becchimanzi, A.; Iuliano, M.; Andolfi, A. The Issue of Misidentification of Kojic Acid with Flufuran in Aspergillus flavus. Molecules 2019, 24, 1709. https://doi.org/10.3390/molecules24091709

AMA Style

DellaGreca M, De Tommaso G, Salvatore MM, Nicoletti R, Becchimanzi A, Iuliano M, Andolfi A. The Issue of Misidentification of Kojic Acid with Flufuran in Aspergillus flavus. Molecules. 2019; 24(9):1709. https://doi.org/10.3390/molecules24091709

Chicago/Turabian Style

DellaGreca, Marina, Gaetano De Tommaso, Maria Michela Salvatore, Rosario Nicoletti, Andrea Becchimanzi, Mauro Iuliano, and Anna Andolfi. 2019. "The Issue of Misidentification of Kojic Acid with Flufuran in Aspergillus flavus" Molecules 24, no. 9: 1709. https://doi.org/10.3390/molecules24091709

Article Metrics

Back to TopTop